03:37 PM EDT, 06/06/2024 (MT Newswires) -- Scilex Holding ( SCLX ) said Thursday that US Food and Drug Administration approved the commercial production of its Gloperba liquid medication for gout.

The distribution of the non-opioid pain treatment will begin next week through wholesalers and pharmacies.

Scilex ( SCLX ) shares were nearly 5% higher in regular trading session.

Price: 1.13, Change: +0.05, Percent Change: +4.63